These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 14500461)

  • 1. Role of CD1d-restricted NKT cells in microbial immunity.
    Sköld M; Behar SM
    Infect Immun; 2003 Oct; 71(10):5447-55. PubMed ID: 14500461
    [No Abstract]   [Full Text] [Related]  

  • 2. CD1d-mediated antigen presentation to natural killer T (NKT) cells.
    Brutkiewicz RR; Lin Y; Cho S; Hwang YK; Sriram V; Roberts TJ
    Crit Rev Immunol; 2003; 23(5-6):403-19. PubMed ID: 15030309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD1-specific T cells in microbial immunity.
    Gumperz JE; Brenner MB
    Curr Opin Immunol; 2001 Aug; 13(4):471-8. PubMed ID: 11498304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
    Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
    Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD1 antigen presentation and infectious disease.
    Dascher CC; Brenner MB
    Contrib Microbiol; 2003; 10():164-82. PubMed ID: 12530326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
    Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
    J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.
    Matsuda JL; Mallevaey T; Scott-Browne J; Gapin L
    Curr Opin Immunol; 2008 Jun; 20(3):358-68. PubMed ID: 18501573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells.
    Motsinger A; Azimzadeh A; Stanic AK; Johnson RP; Van Kaer L; Joyce S; Unutmaz D
    J Virol; 2003 Jul; 77(14):8153-8. PubMed ID: 12829854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of immunity and pathogenesis in infectious diseases by CD1d-restricted NKT cells.
    Hansen DS; Schofield L
    Int J Parasitol; 2004 Jan; 34(1):15-25. PubMed ID: 14711586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy.
    Yu KO; Porcelli SA
    Immunol Lett; 2005 Aug; 100(1):42-55. PubMed ID: 16083968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex.
    Hansen DS; Siomos MA; Buckingham L; Scalzo AA; Schofield L
    Immunity; 2003 Mar; 18(3):391-402. PubMed ID: 12648456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1d-restricted NKT cells: an interstrain comparison.
    Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
    J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for CD1d-restricted NKT cells in injury-associated T cell suppression.
    Faunce DE; Gamelli RL; Choudhry MA; Kovacs EJ
    J Leukoc Biol; 2003 Jun; 73(6):747-55. PubMed ID: 12773507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection.
    Fleuridor R; Wilson B; Hou R; Landay A; Kessler H; Al-Harthi L
    Immunology; 2003 Jan; 108(1):3-9. PubMed ID: 12519296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and function of CD1d-restricted NKT cells: influence of sphingolipids, SAP and sex.
    Sandberg JK; Ljunggren HG
    Trends Immunol; 2005 Jul; 26(7):347-9. PubMed ID: 15925541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of natural killer T cells in antitumor immunotherapy.
    Hong C; Park SH
    Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.